Mario Perro

Critic
DISC Type : C

Chief Scientific Officer at IGI

Epalinges, Vaud, Switzerland

Overview

Mario Perro is the Chief Scientific Officer at IGI, leveraging over a decade of expertise in cancer immunology to develop next-generation immunotherapies. Holding a Ph. D. from University College London, he focuses on antibody-based therapeutics. Colleagues describe him as a driven, committed, and strategic expert in tumor immunology and imaging.

He is a key figure behind the development of ISB 2001, a novel trispecific T-cell engager for multiple myeloma that resulted in a major strategic partnership with Abbvie.

Personality Overview

Negotiator

Precise

Objective Thinker

They like to take decisions independently and do not seek others' support often.  They are quite likely to negotiate on pricing or other key terms. They prefer to analyze logically and value objective facts over emotions.

Topics They Care About

Cancer Immunotherapy
His career at Roche and IGI has been dedicated to advancing cancer immunotherapies, including immune-checkpoint inhibitors, bispecific antibodies, and T-cell engagers.
Multiple Myeloma
His recent publications and company announcements center on developing innovative treatments like the trispecific antibody ISB 2001 for relapsed or refractory multiple myeloma.
Antibody Engineering
He leads research into novel antibody platforms, such as the BEAT® and TREAT™ technologies, to create multi-specific biologics that overcome tumor escape mechanisms.

Media Appearances

Mario has no verified media appearances

Work History

11-2025
Chief Scientific Officer at IGI
5-2024 - 11-2025
Head of Biologics Research & Site Head, SVP at IGI
8-2021 - 5-2024
Vice-President, Head on Oncology Department at IGI
1-2021 - 8-2021
Senior Director Hematologic Malignancies, Immunotherapies at IGI
1-2017 - 1-2021
Principal Scientist, Cancer Immunotherapy, Pharmacology Department, pRED at Roche

Education

2006 - 2010
Doctor of Philosophy (Ph.D.) from University College of London, PhD
2001 - 2006
110/110 from Università degli Studi di Torino

More Information

Social Presence :

Prographics :

Exp : 21 Location : Epalinges, Vaud, Switzerland Job Level : Leadership Designation : Chief Scientific Officer at IGI
URL has been copied!

Insights For Selling To Mario

During A Call Or A Meeting

DO's

  • Don’t forget to mention how you compare to competition on both features and pricing
  • Tell them what ROI they can expect
  • Be formal and objective, they will appreciate it more

DONT's

  • Don't give superficial answers, they are easily rattled by them
  • Avoid pushing them too much to involve other stakeholders unless it is critical
  • Do not use very emotional or colorful language

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Mario is

  • Proof of ROI, low pricing and objective proof points are the important factors for them.
  • Will you ever get a clear answer from Mario

  • They do not mind saying no if they believe that it is the right decision.

Insights For Deal Planning

    How fast (or slow) will Mario move?

  • They are neither the fastest nor the slowest decision makers, they are somewhere in the middle.
  • Can Mario take some risk or not?

  • They can bear some risk if their analysis backs the decision.

You And Mario

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.